scholarly journals Video-assisted thoracoscopic diagnosis of trapped lung in malignant pleural effusions

2018 ◽  
Vol 16 (3) ◽  
pp. 212-217
Author(s):  
P. Bonev ◽  
Iv. Novakov ◽  
I. Dimitrov ◽  
M. Vazheva ◽  
A. Uchikov

PURPOSE. The aim of this study is to present the role of video-assisted thoracoscopy to assess the ability of the lung to expand in malignant pleural effusions. METHODS. The survey was conducted for a 3-year period in 13 patients with histologically diagnosed malignant pleural effusion and trapped lung. In each of the patients video-assisted thoracoscopy was performed. RESULTS. Two reasons for trapped lung were identified. In 10 of the patients it was due to multiple metastatic nodules. In 3 cases the cause was a diffuse fibrotic involvement of the lung resulting from the metastatic process.CONCLUSIONS. Our research confirmed two causes of trapped lung in malignant pleural effusions: multiple metastases on the lung surface and diffuse lung fibrosis, induced by the metastatic process, with the increased role of multiple metastases on the lung surface

2012 ◽  
Vol 139 (4) ◽  
pp. 543-549 ◽  
Author(s):  
Mingming Lv ◽  
Yongbin Mou ◽  
Ping Wang ◽  
Yueqiu Chen ◽  
Tingting Wang ◽  
...  

2020 ◽  
Vol 5 ◽  
pp. 17-17
Author(s):  
Danail Petrov ◽  
Teodora Mihalova ◽  
Daniel Valchev

2012 ◽  
Vol 30 (15_suppl) ◽  
pp. e17542-e17542
Author(s):  
Lei Yu

e17542 Background: Patients with lung adenocarcinoma and malignant pleural effusions have limited life expectancy. The treatment of lung adenocarcinoma with malignant pleural effusions remains controversial. The purpose of our study is to evaluate the use of video-assisted thoracoscopy to perform hyperthermic intrapleural chemotherapy combined with Endostar (recombinant human endostatin) for disseminated pleural adenocarcinoma. Methods: From 2007 to 2010, there were 46 patients with lung adenocarcinoma and pleural dissemination undergoing thoracoscopic surgery and intrathoracic hyperthermic perfusion with chemotherapy in combination of Endostar. After thoracoscopic surgery, the hyperthermic perfusion system was set up for hyperthermic intrapleural chemotherapy. The thoracic cavity was perfused at a speed of approximately 1.8-2.3 L/min with 0.9% normal saline (4-5L), containing cisplatinum (100 mg). The intrathoracic temperature remained between 42°C to 43°C. This process of perfusion lasted for 1 hours. Following this, 2L of 0.45% saline with Endostar (30 mg) at a temperature of 30 °C was put into the pleural cavity and kept for 30 min. Results: There were no peri-operative deaths. During the hyperthermic perfusion, patient's core temperature varied from 36.3ºC and 39.3ºC and pulse from 59 beats/m and 126 beats/m. Intraoperative sinus tachycardia occurred in 2 elderly cases. No hematologic toxicity and nephrotoxicity was observed within one week after surgery. Postoperative pneumonia occurred in 1 elderly case. The median survival time was 21 months. During the follow-up period, only one patient suffered from continuing pleural effusion due to atelectasis, one elderly patient died of heart failure one year after surgery and the remaining patients were completely free from pleural effusion during the last follow-up. Conclusions: Hyperthermic intrapleural chemotherapy combined with Endostar by thoracoscopic surgery offers a safe and effective treatment for lung adenocarcinoma with pleural dissemination. It may be time-consuming, but beneficial and may have an encouraging impact on its long-term survival.


CHEST Journal ◽  
1998 ◽  
Vol 113 (3) ◽  
pp. 739-742 ◽  
Author(s):  
Christopher A. Danby ◽  
Samuel A. Adebonojo ◽  
Dennis M. Moritz

Sign in / Sign up

Export Citation Format

Share Document